Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Scientific Session

Spondyloarthritis (SpA) including psoriatic arthritis (PsA)
General Topic: Pediatric

14T121: Spondyloarthropathy: Comparing Adult and Pediatric Diseases

Tuesday, November 14, 2023
9:00 AM - 10:00 AM PT
Location: Room 7A-B
CE: 1

In Person

    Speaker(s)

  • WM

    Walter P. Maksymowych, MD

    University of Alberta
    Edmonton, AB, Canada

    Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); CARE Arthritis Ltd: Officer or Board Member (Ongoing); CARE Arthritis Ltd.: Officer or Board Member (Ongoing); Celgene: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galapagos: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gilead: Consultant (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • HS

    Hemalatha Srinivasalu, MD, MBBS

    Children's National Hospital
    Washington, DC, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • PW

    Pamela Weiss, MD

    Childrens Hospital of Philadelphia
    Glen Mills, PA, United States

    Disclosure(s): Eli Lilly: Consultant (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing)

Juvenile spondyloarthritis continues to present challenges in diagnosis and treatment with evolving understanding of pathogenesis. The goal of this session is to provide updates with regard to clinical classification, treatment, and pathogenesis, particularly in comparison to adult spondyloarthritis.

Learning Objectives:

  • Increase knowledge of clinical diagnosis and classification of juvenile spondyloarthritis, including early onset, with comparison to adult spondyloarthritis.
  • Review current best practice and updates on imaging of juvenile versus adult spondyloarthritis.
  • Review current best practice and updates on treatment of juvenile spondyloarthritis with comparison to adult spondyloarthritis.

Presentations:

  • 9:00 AM - 9:15 AM PT
    Classification of Early Axial Disease in Spondyloarthritis

    Speaker: Pamela Weiss, MD – Childrens Hospital of Philadelphia

  • 9:15 AM - 9:30 AM PT
    Magnetic Resonance Imaging Evidence of Inflammation and Structural Lesions: Adults Versus Children

    Speaker: Walter P. Maksymowych, MD – University of Alberta

  • 9:30 AM - 9:45 AM PT
    Updates and Differences in Management

    Speaker: Hemalatha Srinivasalu, MD, MBBS – Children's National Hospital

  • 9:45 AM - 10:00 AM PT
    Q&A